Storia dello sviluppo di nuovi farmaci COVID-19 - Pride of Taiwan
FEBICOe Research Center for Emerging Viral Infections (RCEVI), CGU Report a Victory in Cellular Experiments Through Industry-Academia Collaboration Co-pubblica la pioniera "Broad-Spectrum Antiviral Technology" e New Anti-COVID-19 Drug, Apomivir® a Taiwan
Per Saperne Di Più